How many drugs treat Thrombocytopenic disorder?

Drug Landscape tracks 2 marketed treatments for Thrombocytopenic disorder (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/thrombocytopenic-disorder.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Thrombocytopenic disorder — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Thrombocytopenic disorder (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Thrombocytopenic disorder, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Mulpleta	LUSUTROMBOPAG	Vancocin Italia		Thrombopoietin receptor		2018-01-01
Doptelet	AVATROMBOPAG	Akarx Inc		Thrombopoietin receptor		2018-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Akarx Inc · 1 drug in Thrombocytopenic disorder
Vancocin Italia · 1 drug in Thrombocytopenic disorder

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Thrombocytopenic disorder:

Cite this brief

Drug Landscape (2026). Thrombocytopenic disorder — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/thrombocytopenic-disorder. Accessed 2026-06-10.

Thrombocytopenic disorder full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing